Press Releases

Press Release

Altasciences Completes Successful Phase I Trial of Ischemix’ Novel Compound for Treatment of Traumatic Brain Injury (TBI)

Aug 28, 2023

Altasciences is pleased to have completed the successful Phase I trial of Ischemix’ novel drug candidate, CMX-2043, for the treatment of acute traumatic brain injury (TBI), at our Montréal clinical facility.

Press Release

Altasciences Receives 2023 CRO Leadership Award for Capabilities

May 4, 2023

Press Release

Altasciences Completes Clinical Portion of Alzamend Neuro's Phase IIa Multiple Ascending Dose Clinical Trial for Treatment of Dementia Related to Alzheimer's

Apr 18, 2023

Press Release

Altasciences Receives Accreditation From College of American Pathologists

Oct 31, 2022

Press Release

Altasciences Expands Laboratory Capabilities in Columbia

Oct 17, 2022

Press Release

Altasciences Expands Strategic Support for Early Drug Development in Europe and Adds Key Employees to Its Preclinical Team in North America

Oct 13, 2022

Press Release

Hoth Therapeutics Announces the Selection of Altasciences for Manufacturing HT-TBI for Traumatic Brain Injury and Stroke

Sep 20, 2022

Sign up for exclusive content

Stay connected